FEBRUARY 15, 2004
VOLUME 1, NO. 3
 

What to tell your patients

HRT or no HRT

Debilitating symptoms versus the cancer risk. A guide
to finding the middle way

St John's, Nfld gynecologist Dr Terry O'Grady recalls meeting a woman at a public forum shortly after the first wave of public controversy erupted over a 2002 Women's Health Initiative (WHI) study. The now famous study linked hormone replacement therapy (HRT) with an increased risk of breast cancer, heart attacks, strokes and blood clots. The woman was "so absolutely distraught," Dr O'Grady agreed to meet with her privately afterwards.

She had a premalignant breast lesion and several doctors she consulted had refused to prescribe hormones for her severe menopausal symptoms. The Ob/Gyn explained all the possible risks. "The patient said -- and quite rightly -- 'Is it not my risk to take?'"

The HRT storm re-erupted in January when the Canadian Cancer Society (CCS) recommended that, "Due to increased cancer risk, women should avoid combination hormone replacement therapy for any reason other than to relieve severe menopausal symptoms that have not responded to any other treatment." For these women, the Society recommends that the decision regarding HRT be made with a doctor based on the risks and benefits of the medication, including: the woman's individual and family history of breast and ovarian cancer, heart disease, osteoporosis and dementia; how severe the woman's menopausal symptoms are; and how long the woman will be taking HRT.

The Society of Obstetricians and Gynaecologists of Canada (SOGC) countered by reiterating its earlier stand that HRT is a safe and effective option for the treatment of distressing menopausal symptoms. SOGC is concerned that the CCS may be only adding to the confusion and fear regarding the use of HRT.

Dr O'Grady is clearly on the SOGC side. "Sure lots of people will do fine, but there's a big chunk of women with pretty heavy duty jobs and heavy duty responsibilities that need something to get them through." She thinks the CCS conclusion that women should try other, often untested treatments, is wrong and possibly even dangerous.

The CCS has based its position on the original WHI report, which showed a very small increased risk of breast cancer, less than one-tenth of a percent for every year of use. Dr O'Grady says other "overwhelming factors" such as diet, exercise, alcohol consumption and overall weight were not addressed.

For those determined to stop using HRT she advises they wean themselves off slowly. "An awful lot of women say they just can't cope [without HRT]," says the doctor.

 

 

back to top of page

 

WHAT TO TELL YOUR
PATIENTS ABOUT HRT

  • The WHI study on wich the cautions were based found a small increased risk of breast cancer in women after five years of HRT (eight additional cases per 10,000 women per year). Two-thirds of the study's participants were between 60 and 80 years of age and 70% were overweight.
  • There was a slight increased risk of heart attack and stroke among the participants (six and eight extra cases per 10,000 women per year respectively over the course of the study.) However, in women aged 50-59, the risk of strokes attributed to hormones was much lower, four per 10,000 women.
  • The SOGC notes that of the more than 8,000 women on continuous combined HRT in the WHI study, 97.5% had no adverse outcomes.
  • The SOGC maintains that HRT continues to be an option for menopausal women with the caution that the lowest effective dose be given for the shortest time needed.
  • Should you be uncomfortable with putting a given patient on HRTs, consider the alternatives the CCS recommends:
- Regular physical activity to relieve stress and improve overall well-being during menopause.
- Relaxation techniques to modify stress levels;
- Vitamin E supplements, chamomile tea or tea containing valerian at bedtime. - Wearing light clothing in layers that can be removed to cope with hot flashes.
- For symptoms of vaginal dryness, water-soluble lubricants, Vitamin E vaginal suppositories, estrogen rings or creams can be used.

- The CCS points out, however, that not all of these alternatives have been tested to evaluate side effects.
 
© Parkhurst Publishing 1994-2003 Privacy Statement
Legal Terms of Use
Site created by Spin Design T.